Autologous for Lymphomas – Stem Cell Transplant :-

A stem cell transplant is a procedure that replaces damaged or affected stem cells with better ones in your bone marrow. It is sometimes called a ‘peripheral blood stem cell transplant’ or a ‘bone marrow transplant’. Most stem cell transplants nowadays use stem cells collected from the bloodstream. We refer to both as ‘stem cell transplants’ in the rest of our information.

There are chances that a high chemotherapy dose might also destroy the cells in the bone marrow. Hence, this treatment is opted at its best.

What kinds of Lymphoma can stem cell transplant treat?

A stem cell transplant allows you to be treated with a higher dose of chemotherapy than you would usually be able to have because it replaces the stem cells damaged by chemotherapy. A stem cell transplant helps you to be treated with even a higher dose of chemotherapy than you would usually be able to have. This replaces the stem cells damaged by chemotherapy. There are three major kinds of Lymphoma that are treated which are:

• Hodgkin lymphoma
• High-grade non-Hodgkin lymphoma
• Low-grade non-Hodgkin lymphoma

Pediatric Bone Marrow Transplant :-

A bone marrow transplant (BMT) is a treatment for children. They are diagnosed usually with certain types of cancer or other diseases. The goal of BMT is to replace a child’s diseased bone marrow with healthy bone marrow. The major objective of BMT is to establish healthy bone marrow cells into a person after his or her own unhealthy bone marrow has been eliminated.

Why does a child need BMT?

There are certain conditions that are supposed to be met by the child before they are recommended BMT. A child suffering from diseases like Leukemia, Aplastic anemia, and sickle cell anemia. Also, it can include those who need replacement of bone marrow after high doses of chemotherapy or radiation are given to treat cancer.

5 stages of the BMT :-

Every child has to get through these 5 important stages of BMT. These include:

• Consultation, Test & Examination
• Harvesting
• Conditioning
• Transplanting the stem cells
• Recovery

Thalassemia Transplant :-

Hematopoietic cell transplantation (HCT) is the only treatment that offers reasonable control for a cure for thalassemia at this time. HCT relies on high-dose chemotherapy to eliminate thalassemia-producing cells in the marrow. It replaces them with healthy donor cells from bone marrow or umbilical cord blood. It is usually taken from a human-leukocyte antigen (HLA) match: an identical sibling.

This therapy should be chosen by all the patients who have a suitable donor. Early referral to a transplant center is recommended, as HCT has a better outcome in younger patients.

What are the major risk factors involved?

There are some risk factors that are needed to pay attention to. This makes the treatment a necessary condition for some, these factors are:

• age of the patient
• adequacy of chelation
• the presence or absence of liver fibrosis
• the presence or absence of hepatomegaly

Since HLA-matched sibling transplantation in healthy thalassemia patients offers a very high cure rate, stem cell options for families without matched siblings are being studied. Most patients do not have an HLA-matched sibling. Experimental trials with unrelated, matched umbilical cord blood or stem cell transplantation are being conducted. Alternative immunosuppressive preparations and therapy are being studied to decrease graft-versus-host disease and improve graft survival. Pregnant mothers of affected children are more frequently undergoing prenatal diagnosis for thalassemia and determining a fetal HLA typing on the prenatal sample.